The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19.
The Home Test to Treat program now offers free testing, telehealth and treatment for both COVID-19 and flu to eligible adults nationwide, the National Institutes of Health announced.
Flu-associated medical visits and hospitalizations per 100,000 population in 2022-23 were higher among children under age 5 than for older children, but were higher for older children than for any season since 2016-17, the Centers for Disease Control and Prevention reported Oct. 12.
The AHA has excellent resources to help hospital and health system teams encourage patients and people in their communities to get vaccinated against the flu, COVID-19 and RSV.
The AHA Sept. 25 launched its 2023-24 United Against the Flu campaign to help hospitals and health systems encourage their communities to get vaccinated for the current flu season.
This season’s flu vaccines for the Southern Hemisphere have reduced the risk of being hospitalized for flu by 52%, based on mid-season data from five countries, suggesting the U.S. vaccines could provide similar protection if similar viruses continue to predominate, the Centers for Disease Control…
The Food and Drug Administration announced its approval of Pfizer’s Abrysvo (Respiratory Syncytial Virus Vaccine), the first vaccine approved for use in pregnant individuals to prevent lower respiratory tract disease and severe LRTD caused by respiratory syncytial virus in infants from birth…
Vaccines are powerful weapons against most diseases. Nearly a dozen serious diseases —including polio, smallpox and whooping cough — have been eradicated because of vaccines. That’s important to remember as we observe National Immunization Awareness Month in August.
Learn how Advocate Children's Hospital is managing the “immunity gap” created by social distancing to persevere through the triple threat of COVID-19, RSV and flu.
Some experts have suggested that RSV (respiratory syncytial virus) was more severe last year because of an immunity gap from several years of social distancing and COVID-19 precautions.